Loxo Oncology financials

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

CreditSafe score

Score changed on Mar 27, 2023

Premium Content

USD	FY, 2014	FY, 2015	FY, 2016	FY, 2017
General and administrative expense	6.2M	10.5M	14.9M	33.7M
Operating expense total	13.1M	24.5M	73.2M	173.7M
EBIT	(20.7M)		(73.2M)	(152.4M)
Interest expense	18.0K	199.0K	780.0K	3.5M
Pre tax profit	20.7M	(36.1M)	(72.4M)
Net Income	(20.7M)	(35.9M)	(72.4M)	(148.9M)